Artenimol | Interleukin Related interleukin-related.com

Product Name :
Artenimol

Search keywords :
Dihydroartemisinin

drugId :
null

Target Vo:
Cytochrome P450

Target Vo Short Name :
CYPs

Moa_Name:
Cytochrome P450 inhibitors

First Approval Country :

First Approval Date Filter:
1992

Origin Company_Name :
Shanghai Institute Of Materia Medica, Chinese Academy Of Sciences

Active Company_Name :
Barcelona Institute For Global Health

Active Indication_Name:
Malaria

In Active Indication_Name:
Malaria, Falciparum

Termination Status :

China Termination Status :

Highest Status:
Approved

China Highest Status:
Phase 2 Clinical

Antibodies are immunoglobulins secreted by effector lymphoid B cells into the bloodstream. Antibodies consist of two light peptide chains and two heavy peptide chains that are linked to each other by disulfide bonds to form a “Y” shaped structure. Both tips of the “Y” structure contain binding sites for a specific antigen. Antibodies are commonly used in medical research, pharmacological research, laboratory research, and health and epidemiological research. They play an important role in hot research areas such as targeted drug development, in vitro diagnostic assays, characterization of signaling pathways, detection of protein expression levels, and identification of candidate biomarkers.
Related websites: https://www.medchemexpress.com/antibodies.html
Popular product recommendations:
Epcoritamab References
Teclistamab Immunology/Inflammation
Vitamin D Binding Protein Antibody: Vitamin D Binding Protein Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 53 kDa, targeting to Vitamin D Binding Protein. It can be used for WB,ICC/IF assays with tag free, in the background of Human, Mouse, Rat.

Author: Interleukin Related

Related Posts